Jo Van Damme Selected Research

Cautery

10/2021

The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jo Van Damme Research Topics

Disease

48	Inflammation (Inflammations) 03/2023 - 01/2002
29	Neoplasms (Cancer) 03/2023 - 07/2002
19	Infections 01/2021 - 01/2002
13	Uveitis 04/2022 - 09/2004
12	Rheumatoid Arthritis 01/2023 - 03/2002
12	Neoplasm Metastasis (Metastasis) 01/2012 - 07/2002
11	Autoimmune Diseases (Autoimmune Disease) 03/2023 - 01/2003
8	Multiple Sclerosis 01/2018 - 01/2003
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 08/2006
5	Arthritis (Polyarthritis) 01/2023 - 01/2006
5	Carcinoma (Carcinomatosis) 07/2010 - 07/2002
4	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
4	Epiretinal Membrane (Epiretinal Membranes) 01/2020 - 09/2006
4	Necrosis 01/2020 - 01/2006
4	Virus Diseases (Viral Diseases) 01/2016 - 11/2008
4	Melanoma (Melanoma, Malignant) 11/2014 - 06/2007
3	Atherosclerosis 01/2023 - 02/2011
3	Wounds and Injuries (Trauma) 01/2022 - 01/2016
3	Pathologic Processes 01/2016 - 07/2005
3	Experimental Arthritis 01/2009 - 04/2007
2	Osteoarthritis 01/2023 - 03/2002
2	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2014
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2018 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 07/2004
2	Neuroinflammatory Diseases 01/2014 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2011 - 07/2010
2	Cerebral Malaria 05/2010 - 04/2008
2	Carcinogenesis 08/2009 - 08/2008
2	Sarcoma (Soft Tissue Sarcoma) 12/2007 - 01/2003
2	Retinal Detachment (Retinal Detachments) 09/2006 - 08/2006
2	Crystal Arthropathies 01/2006 - 05/2004
2	Infectious Arthritis (Septic Arthritis) 05/2004 - 11/2003
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 04/2022
1	Fibrosis (Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

68	ChemokinesIBA 08/2021 - 07/2002
22	CytokinesIBA 03/2023 - 05/2004
16	LigandsIBA 03/2023 - 10/2003
14	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
11	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 03/2002
11	CXC ChemokinesIBA 11/2014 - 01/2004
9	EnzymesIBA 01/2023 - 03/2002
9	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2002
8	Peptides (Polypeptides)IBA 01/2022 - 01/2002
8	Chemotactic FactorsIBA 04/2018 - 11/2003
7	Interleukin-8 (Interleukin 8)IBA 04/2018 - 01/2003
5	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2009
5	InterferonsIBA 08/2021 - 11/2003
5	Protein Isoforms (Isoforms)IBA 08/2021 - 07/2002
5	ImmunosorbentsIBA 01/2020 - 09/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 01/2006
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 06/2015
4	EpitopesIBA 01/2023 - 03/2002
4	GlycosaminoglycansIBA 01/2022 - 01/2014
4	InterleukinsIBA 08/2019 - 01/2009
4	CC ChemokinesIBA 02/2019 - 02/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 06/2007
4	Interleukin-17 (Interleukin 17)IBA 08/2012 - 12/2007
4	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 11/2003
4	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2010 - 11/2003
3	Monoclonal AntibodiesIBA 03/2023 - 01/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 02/2003
3	oxyamylose (COAM)IBA 01/2022 - 11/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 02/2011
3	Complement System Proteins (Complement)IBA 01/2021 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2019 - 01/2016
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2019 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 08/2019 - 05/2011
3	Protein-Arginine DeiminasesIBA 01/2013 - 09/2008
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
3	Chemokine CXCL6IBA 12/2007 - 01/2004
3	Chemokine CCL4IBA 09/2006 - 10/2002
3	Chemokine CCL3IBA 09/2004 - 10/2002
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2023 - 12/2019
2	Matrix Metalloproteinase InhibitorsIBA 01/2023 - 01/2014
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	AutoantibodiesIBA 01/2021 - 01/2020
2	GelatinasesIBA 01/2021 - 09/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2020 - 06/2007
2	Retinaldehyde (Retinal)IBA 01/2020 - 02/2015
2	AutoantigensIBA 01/2020 - 01/2003
2	Interleukin-6 (Interleukin 6)IBA 12/2019 - 01/2016
2	Chemokine CXCL12IBA 01/2016 - 07/2010
2	Immunologic Factors (Immunomodulators)IBA 07/2013 - 07/2013
2	CitrullineIBA 01/2013 - 09/2010
2	Arginine (L-Arginine)FDA Link 01/2013 - 01/2004
2	Interleukin-15 (Interleukin 15)IBA 08/2012 - 05/2011
2	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 01/2012 - 10/2011
2	Amino Acids FDA Link 02/2011 - 01/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010 - 03/2007
2	Chemokine CCL18IBA 11/2003 - 07/2002
1	Immune Sera (Antisera)IBA 03/2023
1	AmyloseIBA 01/2022

Therapy/Procedure

14	Therapeutics 03/2023 - 01/2004
2	Immunomodulation 01/2021 - 01/2018
2	Investigational Therapies (Experimental Therapy) 04/2018 - 10/2012
1	Precision Medicine 01/2023
1	Cautery 10/2021